GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 90 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $14,436,000 | +39.9% | 1,179,391 | +34.9% | 0.00% | 0.0% |
| Q3 2016 | $10,316,000 | +65.3% | 874,241 | +21.9% | 0.00% | +100.0% |
| Q2 2016 | $6,240,000 | +62.0% | 717,276 | -1.9% | 0.00% | 0.0% |
| Q1 2016 | $3,852,000 | -32.5% | 730,923 | -0.6% | 0.00% | 0.0% |
| Q4 2015 | $5,704,000 | +1.3% | 735,033 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $5,631,000 | -3.1% | 715,555 | +11.5% | 0.00% | 0.0% |
| Q2 2015 | $5,813,000 | -29.0% | 641,632 | +1.7% | 0.00% | 0.0% |
| Q1 2015 | $8,188,000 | +17.6% | 630,838 | +23.3% | 0.00% | 0.0% |
| Q4 2014 | $6,964,000 | +69.8% | 511,701 | +11.9% | 0.00% | 0.0% |
| Q3 2014 | $4,102,000 | -38.7% | 457,297 | -7.5% | 0.00% | 0.0% |
| Q2 2014 | $6,692,000 | +62.9% | 494,615 | +19.7% | 0.00% | 0.0% |
| Q1 2014 | $4,109,000 | -24.6% | 413,359 | +0.8% | 0.00% | 0.0% |
| Q4 2013 | $5,449,000 | +3.3% | 410,031 | -5.6% | 0.00% | 0.0% |
| Q3 2013 | $5,274,000 | +61.3% | 434,438 | +37.5% | 0.00% | 0.0% |
| Q2 2013 | $3,269,000 | – | 315,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |